0002006018-23-000001.txt : 20231228 0002006018-23-000001.hdr.sgml : 20231228 20231228111726 ACCESSION NUMBER: 0002006018-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231228 DATE AS OF CHANGE: 20231228 EFFECTIVENESS DATE: 20231228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AdvanCell Isotopes Pty Ltd CENTRAL INDEX KEY: 0002006018 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: C3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500933 FILM NUMBER: 231520714 BUSINESS ADDRESS: STREET 1: LEVEL 7/167 MACQUAIRE ST CITY: SYDNEY NSW STATE: C3 ZIP: 2000 BUSINESS PHONE: 978-421-6527 MAIL ADDRESS: STREET 1: LEVEL 7/167 MACQUAIRE ST CITY: SYDNEY NSW STATE: C3 ZIP: 2000 D 1 primary_doc.xml X0708 D LIVE 0002006018 AdvanCell Isotopes Pty Ltd LEVEL 7/167 MACQUAIRE ST SYDNEY NSW C3 AUSTRALIA 2000 978-421-6527 AUSTRALIA None None Corporation true 2019 Andrew Adamovich Level 7/167 Macquarie St Sydney NSW 2000 C3 AUSTRALIA 2000 Executive Officer Chief Executive Officer Michael Tung 3020 Scott St San Francisco CA CALIFORNIA 94123 Executive Officer Chief Financial Officer Simon Puttick Level 7/167 Macquarie St Sydney NSW C3 AUSTRALIA 2000 Executive Officer Director Chief Scientific Officer; Chief Operations Officer William Ferris Level 7/167 Macquarie St Sydney NSW C3 AUSTRALIA 2000 Director Anthony Aiudi Level 7/167 Macquarie St Sydney NSW C3 AUSTRALIA 2000 Director Kevin Cameron Level 7/167 Macquarie St Sydney NSW C3 AUSTRALIA 2000 Director Adrian Paterson Level 7/167 Macquarie St Sydney NSW C3 AUSTRALIA 2000 Director Biotechnology Decline to Disclose 06b false 2023-12-07 false true true true false 5000000 10000000 5000000 5000000 Single Investor; two tranches false 1 0 true 0 true Chief Financial Officer 0 true Chief Scientific Officer, Chief Operations Officer false AdvanCell Isotopes Pty Ltd Andrew Adamovich Andrew Adamovich Chief Executive Officer 2023-12-27